Stock 0VY I-MAB
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart I-Mab Deutsche Boerse AG

Equities

0VY

US44975P1030

Real-time Estimate Tradegate
Other stock markets
 07:18:49 2024-07-12 am EDT 		5-day change 1st Jan Change
1.435 EUR +3.99% Intraday chart for I-Mab +2.13% -12.73%
Jun. 06 I-Mab Appoints Phillip Dennis as Chief Medical Officer CI
Jun. 05 I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
I-MAB
Other Pharmaceuticals
+4.35%+2.13%-12.73%-41.94% - 128M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. IMAB Stock
  4. 0VY Stock
  5. Charts I-Mab
  6. Comparison Chart